It has been reported that the abnormally high expression of vimentin in various epithelial cancers including prostate cancer, gastrointestinal tumors, and breast cancer is closely related to tumor growth, invasion, and poor prognosis (Satelli and Li, 2011). This evidence concerns the gene VIM and breast cancer.